131 related articles for article (PubMed ID: 20232485)
41. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
Izraeli S
Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
[TBL] [Abstract][Full Text] [Related]
42. Trisomy 21 mosaicism: we may all have a touch of Down syndrome.
Hultén MA; Jonasson J; Iwarsson E; Uppal P; Vorsanova SG; Yurov YB; Iourov IY
Cytogenet Genome Res; 2013; 139(3):189-92. PubMed ID: 23306383
[TBL] [Abstract][Full Text] [Related]
43. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
Laurent AP; Kotecha RS; Malinge S
Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
[TBL] [Abstract][Full Text] [Related]
44. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
Dewald GW; Diez-Martin JL; Steffen SL; Jenkins RB; Stupca PJ; Burgert EO
Am J Med Genet Suppl; 1990; 7():247-50. PubMed ID: 2149957
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
[TBL] [Abstract][Full Text] [Related]
46. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q.
Cavani S; Perfumo C; Argusti A; Pierluigi M; Perroni L; Schmiegelow K; Petersen MB; Cotter FE; Strigini P; Dagna-Bricarelli F; Nizetić D
Br J Haematol; 1998 Oct; 103(1):213-6. PubMed ID: 9792310
[TBL] [Abstract][Full Text] [Related]
47. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
[TBL] [Abstract][Full Text] [Related]
48. [Trisomy 21 and cancers].
Ayed W; Gouas L; Penault-Llorca F; Amouri A; Tchirkov A; Vago P
Morphologie; 2012 Oct; 96(314-315):57-66. PubMed ID: 23141635
[TBL] [Abstract][Full Text] [Related]
49. Malignancy in children with trisomy 21.
Rabin KR; Whitlock JA
Oncologist; 2009 Feb; 14(2):164-73. PubMed ID: 19176633
[TBL] [Abstract][Full Text] [Related]
50. RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia.
Gialesaki S; Bräuer-Hartmann D; Issa H; Bhayadia R; Alejo-Valle O; Verboon L; Schmell AL; Laszig S; Regényi E; Schuschel K; Labuhn M; Ng M; Winkler R; Ihling C; Sinz A; Glaß M; Hüttelmaier S; Matzk S; Schmid L; Strüwe FJ; Kadel SK; Reinhardt D; Yaspo ML; Heckl D; Klusmann JH
Blood; 2023 Mar; 141(10):1105-1118. PubMed ID: 36493345
[TBL] [Abstract][Full Text] [Related]
51. Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndrome.
Sas V; Blag C; Pasca S; Popa G; Marian M; Schnell C; Voda D; Arghirescu ST; Teodorescu P; Iluta S; Turcas C; Selicean C; Bojan A; Zdrenghea M; Serban M; Dima D; Zaharie G; Colita A; Man S; Tomuleasa C
J BUON; 2020; 25(6):2737-2746. PubMed ID: 33455121
[TBL] [Abstract][Full Text] [Related]
52. Solid malignancies in individuals with Down syndrome: a case presentation and literature review.
Bratman SV; Horst KC; Carlson RW; Kapp DS
J Natl Compr Canc Netw; 2014 Nov; 12(11):1537-45. PubMed ID: 25361800
[TBL] [Abstract][Full Text] [Related]
53. Down syndrome, RASopathies, and other rare syndromes.
Kratz CP; Izraeli S
Semin Hematol; 2017 Apr; 54(2):123-128. PubMed ID: 28637616
[TBL] [Abstract][Full Text] [Related]
54. Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view.
Hasaart KAL; Bertrums EJM; Manders F; Goemans BF; van Boxtel R
Expert Rev Mol Med; 2021 Apr; 23():e5. PubMed ID: 33902785
[TBL] [Abstract][Full Text] [Related]
55. Increased levels of mutagen-induced chromosome breakage in Down syndrome children with malignancy.
Ankathil R; Kusumakumary P; Nair MK
Cancer Genet Cytogenet; 1997 Dec; 99(2):126-8. PubMed ID: 9398867
[TBL] [Abstract][Full Text] [Related]
56. The "Atlas of genetics and cytogenetics in oncology and haematology" on the internet and a review on infant leukemias.
Huret JL; Dessen P; Le Minor S; Bernheim A
Cancer Genet Cytogenet; 2000 Jul; 120(2):155-9. PubMed ID: 10942808
[TBL] [Abstract][Full Text] [Related]
57. Malignancies in Down syndrome.
Kusumakumary P; Vats TS; Ankathil R; Gattamaneni HR; Nair MK
Indian J Pediatr; 1997; 64(6):873-8. PubMed ID: 10771932
[TBL] [Abstract][Full Text] [Related]
58. The Prenatal Origin of Childhood Leukemia: Potential Applications for Epidemiology and Newborn Screening.
Marcotte EL; Spector LG; Mendes-de-Almeida DP; Nelson HH
Front Pediatr; 2021; 9():639479. PubMed ID: 33968846
[TBL] [Abstract][Full Text] [Related]
59. [Value of chromosome examination].
SOLARI AJ
Medicina (B Aires); 1963; 23():109-11. PubMed ID: 13977995
[No Abstract] [Full Text] [Related]
60. Down syndrome iPSC model: endothelial perspective on tumor development.
Perepitchka M; Galat Y; Beletsky IP; Iannaccone PM; Galat V
Oncotarget; 2020 Sep; 11(36):3387-3404. PubMed ID: 32934781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
